Kawano-Sugaya, Tetsuro
Izumiyama, Shinji
Yanagawa, Yasuaki
Saito-Nakano, Yumiko
Watanabe, Koji
Kobayashi, Seiki
Nakada-Tsukui, Kumiko
Nozaki, Tomoyoshi https://orcid.org/0000-0003-1354-5133
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18fk0108046, 19fk0108049j1103, JP17fm0108017)
Japan Society for the Promotion of Science (KAKENHI JP26293093, JP17K19416, and JP18H02650)
Grant from the National Center for Global Health and Medicine Intramural Research Fund (29–2013)
Grant for Science and Technology Research Partnership for Sustainable Development (SATREPS) from AMED and Japan International Cooperation Agency
Article History
Received: 7 June 2020
Accepted: 20 October 2020
First Online: 23 November 2020
Change Date: 24 January 2021
Change Type: Update
Change Details: The original article was missing its Extended Data files as Additional files. The article has been updated to include the missing files.
Ethics approval and consent to participate
: Written informed consent was obtained from all participants <i>Entamoeba histolytica</i> clinical strains were isolated from. This study was approved by the ethics committee of the National Center for Global Health and Medicine Center (approval no. NCGM-G-001566-02). This study was implemented in accordance with the provisions of the Declaration of Helsinki.
: Not Applicable.
: The authors declare that they have no competing interests.